NO20055144L - Preparat for behandling av mikrobielle og parasittiske infeksjoner hos storfe og andre dyr. - Google Patents

Preparat for behandling av mikrobielle og parasittiske infeksjoner hos storfe og andre dyr.

Info

Publication number
NO20055144L
NO20055144L NO20055144A NO20055144A NO20055144L NO 20055144 L NO20055144 L NO 20055144L NO 20055144 A NO20055144 A NO 20055144A NO 20055144 A NO20055144 A NO 20055144A NO 20055144 L NO20055144 L NO 20055144L
Authority
NO
Norway
Prior art keywords
cattle
treatment
parasitic infections
microbial
animals
Prior art date
Application number
NO20055144A
Other languages
English (en)
Norwegian (no)
Inventor
Dale E Shuster
David G Sawutz
Kanwal J Varma
Original Assignee
Schering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd
Publication of NO20055144L publication Critical patent/NO20055144L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • A61K31/277Nitriles; Isonitriles having a ring, e.g. verapamil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/655Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20055144A 2003-04-03 2005-11-02 Preparat for behandling av mikrobielle og parasittiske infeksjoner hos storfe og andre dyr. NO20055144L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46012603P 2003-04-03 2003-04-03
PCT/US2004/010143 WO2004089355A2 (en) 2003-04-03 2004-04-01 Compositions for treating microbial and parasitic infections in cattle and other animals

Publications (1)

Publication Number Publication Date
NO20055144L true NO20055144L (no) 2005-11-02

Family

ID=33159732

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055144A NO20055144L (no) 2003-04-03 2005-11-02 Preparat for behandling av mikrobielle og parasittiske infeksjoner hos storfe og andre dyr.

Country Status (22)

Country Link
US (1) US20040198704A1 (pl)
EP (1) EP1608356A2 (pl)
JP (1) JP2006522147A (pl)
KR (1) KR20060021821A (pl)
CN (1) CN1767822A (pl)
AR (1) AR043824A1 (pl)
AU (1) AU2004227997A1 (pl)
BR (1) BRPI0419273A (pl)
CA (1) CA2519380A1 (pl)
CL (1) CL2004000710A1 (pl)
EC (1) ECSP056074A (pl)
HK (1) HK1080366A1 (pl)
MX (1) MXPA05010693A (pl)
NO (1) NO20055144L (pl)
NZ (1) NZ542379A (pl)
PE (1) PE20050099A1 (pl)
PL (1) PL378820A1 (pl)
RU (1) RU2359667C2 (pl)
TW (1) TW200503682A (pl)
UA (1) UA82359C2 (pl)
WO (1) WO2004089355A2 (pl)
ZA (1) ZA200507857B (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200505425A (en) 2003-05-29 2005-02-16 Schering Plough Ltd Compositions and method for treating infection in cattle and swine
US7439268B2 (en) * 2003-07-18 2008-10-21 Idexx Laboratories Compositions containing prodrugs of florfenicol and methods of use
GB0501220D0 (en) * 2005-01-21 2005-03-02 Norbrook Lab Ltd Anthelmintic composition
CN101128113B (zh) * 2005-02-24 2013-10-30 辛根塔参与股份公司 胶囊制剂
CA2672795A1 (en) 2006-12-13 2008-06-26 Schering-Plough Ltd. Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
US7550625B2 (en) * 2007-10-19 2009-06-23 Idexx Laboratories Esters of florfenicol
CA2706448C (en) * 2007-11-26 2016-08-16 Merial Limited Solvent systems for pour-on formulations for combating parasites
US20090170954A1 (en) * 2007-12-14 2009-07-02 Schering-Plough Ltd. Process for Recovering Florfenicol and Florfenicol Analogs
CN102131772B (zh) 2008-07-30 2015-03-11 英特威国际有限公司 用作氟苯尼考的中间体的*唑啉-保护的氨基二醇化合物的制备方法
RU2397753C1 (ru) * 2009-05-12 2010-08-27 Общество с ограниченной ответственностью "Алвис" Композиция для лечения бактериальных инфекций у животных
KR101473979B1 (ko) * 2013-01-18 2014-12-26 한국썸벧(주) 마보플록사신을 포함하는 약제학적 조성물
RU2641962C2 (ru) * 2013-07-03 2018-01-23 С.П. Ветеринариа, С.А. Инъецируемая ветеринарная композиция
EP3023092A1 (en) * 2014-11-20 2016-05-25 Ceva Sante Animale Eprinomectin parenteral compositions
RU2649809C2 (ru) * 2015-03-03 2018-04-04 Общество с ограниченной ответственностью "Научно-внедренческий центр "Агроветзащита" Жидкая гомогенная фаза для трансдермальных фармацевтических композиций
CN105079000B (zh) * 2015-09-22 2018-07-06 佛山市南海东方澳龙制药有限公司 一种组合物及其应用、制剂
CN105796488A (zh) * 2016-03-23 2016-07-27 张先碧 一种氟苯尼考溶液制剂及其制备方法
US9943387B2 (en) 2016-06-29 2018-04-17 International Business Machines Corporation Unmanned aerial vehicle-based system for livestock parasite amelioration
BR112019012861A2 (pt) * 2016-12-23 2019-12-10 Intervet Int Bv compostos para o tratamento de doença respiratória bovina ou suína
KR102647267B1 (ko) * 2021-06-29 2024-03-18 대한뉴팜(주) 툴라스로마이신과 톨페남산의 복합 주사제 제제

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4199569A (en) * 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
US5733566A (en) * 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
US5082863A (en) * 1990-08-29 1992-01-21 Schering Corporation Pharmaceutical composition of florfenicol
US5773422A (en) * 1996-01-29 1998-06-30 Komer; Gene Avermectin formulation
US6074657A (en) * 1997-03-20 2000-06-13 Pharmacia & Upjohn Company Administration of an injectable antibiotic in the ear of an animal
US6174540B1 (en) * 1998-09-14 2001-01-16 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated caster oil
US6340672B1 (en) * 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation
US6787568B1 (en) * 2000-11-27 2004-09-07 Phoenix Scientific, Inc. Antibiotic/analgesic formulation and a method of making this formulation
RU2263117C2 (ru) * 2001-04-27 2005-10-27 Пфайзер Продактс Инк. Способ получения 4"-замещенных производных 9-деоксо-9а-аза-9а-гомоэритромицина а
US20030068339A1 (en) * 2001-10-02 2003-04-10 Phoenix Scientific, Inc. Veterinary florfenicol formulation that is syringeable under cold weather conditions
US6790867B2 (en) * 2002-05-20 2004-09-14 Schering-Plough Animal Health Corporation Compositions and method for treating infection in cattle and swine
NZ520295A (en) * 2002-07-19 2005-04-29 Ashmont Holdings Ltd Anthelmintic formulations comprising levamisole and either an avermectin or milbemycin
US6653288B1 (en) * 2002-09-30 2003-11-25 Virbac S.A. Injectable anthelmintic compositions and methods for using same
US20040091579A1 (en) * 2002-11-13 2004-05-13 Rubicon Scientific Llc; Extruded foodstuffs having maintenance level actives
TW200505425A (en) * 2003-05-29 2005-02-16 Schering Plough Ltd Compositions and method for treating infection in cattle and swine

Also Published As

Publication number Publication date
PL378820A1 (pl) 2006-05-29
UA82359C2 (uk) 2008-04-10
WO2004089355A2 (en) 2004-10-21
CL2004000710A1 (es) 2005-05-27
WO2004089355A8 (en) 2005-11-03
JP2006522147A (ja) 2006-09-28
CN1767822A (zh) 2006-05-03
BRPI0419273A (pt) 2008-07-15
EP1608356A2 (en) 2005-12-28
ZA200507857B (en) 2007-04-25
RU2359667C2 (ru) 2009-06-27
CA2519380A1 (en) 2004-10-21
US20040198704A1 (en) 2004-10-07
RU2005133875A (ru) 2006-03-20
AR043824A1 (es) 2005-08-17
PE20050099A1 (es) 2005-02-28
NZ542379A (en) 2009-01-31
AU2004227997A1 (en) 2004-10-21
TW200503682A (en) 2005-02-01
MXPA05010693A (es) 2005-12-12
ECSP056074A (es) 2006-03-01
WO2004089355A3 (en) 2005-01-20
HK1080366A1 (zh) 2006-04-28
KR20060021821A (ko) 2006-03-08

Similar Documents

Publication Publication Date Title
NO20055144L (no) Preparat for behandling av mikrobielle og parasittiske infeksjoner hos storfe og andre dyr.
NO20056223L (no) Preparat til behandling av infeksjon hos kveg og svin
UA81629C2 (ru) Применение композиции и способ лечения инфекционных заболеваний крупного рогатого скота и свиней
BRPI0416796A (pt) compostos orgánicos
BR0313148A (pt) Formulações de liberação controlada compreendendo lamotrigina
NO20054164L (no) Immunoglobulinformulering og fremgangsmåte for fremstilling derav
MXPA03000041A (es) Composiciones orales que comprenden agentes microbianos.
DK1412384T3 (da) Stabil formulering af modificeret GLP-1
CY1105202T1 (el) Διασπειρομενες φαρμακευτικες συνθεσεις
CY1107480T1 (el) Χρηση aivlosin για την θepαπευτικη αγωγη και προληψη λοιμωξεων lawsonia σε χοιρους
DE602007004093D1 (de) 3-substituierte n-(aryl- oder heteroaryl)pyrazoä1,5-aüpyrimidine als kinaseinhibitoren
ITFI20030058A1 (it) Formulazioni farmaceutiche contenenti tiazolidinedioni
BRPI0510449A (pt) uso de formulações de meloxicam em medicina veterinária
DK1228758T3 (da) Anvendelse af sulfodehydroabietinsyre til behandling af inflammatorisk tarmsygdom
BRPI0416376A (pt) composições para a redução da colonização bacteriana e da invasão do snc e métodos de uso destes
CY1114480T1 (el) Συνθεσεις που περιλαμβανουν διαχωρισμενο αγωνιστη υποδοχεα γλυκοκορτικοειδους για τη θεραπεια ή τον ελεγχο φλεγμονης προσθιου τμηματος
BRPI0407368A (pt) tratamento de doenças bacterianas dos órgãos respiratórios mediante aplicação local e fluor-quinolonas.
ECSP045405A (es) Penems 6-alquiliden heterotriciclil como inhibidores de la beta lactamasa
UY31058A1 (es) Formulaciones de aminoacido n-halogenado con compuestos antiinflamatorios
DK1251874T3 (da) Stabile farmaceutiske kompositioner og fremgangsmåde til fremstilling af disse, der omfatter et antibiotikum og et slimdrivende middel
WO2006113907A3 (en) Escherichia coli o157:h7 proteins and uses thereof
BRPI0411524A (pt) formulação farmacêutica de amoxicilina e clavulanato, uso de carboximetilcelulose de sódio, e, método de tratar infecção bacteriana em pacientes pediátricos
BRPI0414223A (pt) uso de extratos de gentiana lutea como um agente antimicrobiano
WO2011009771A3 (en) Immunogenic and therapeutic compositions for streptococcus suis
EA200401523A1 (ru) Способы применения и композиции для диагностики и лечения инфекционного заболевания

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application